Why is Aarti Drugs falling/rising?

As of 19-Sep, Aarti Drugs Ltd is experiencing a price increase, with its current price at 524.95, reflecting a change of 8.75 or 1.7% upward. The stock has shown positive performance today, outperforming its sector by 1.43% and achieving a consecutive gain over the last three days, with a total return of 3.14% during this period. It reached an intraday high of Rs 534.15, indicating strong upward momentum. Additionally, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite a decrease in delivery volume by 36.56% compared to the 5-day average, the stock maintains a high management efficiency with a return on capital employed (ROCE) of 17.84% and a low debt-to-equity ratio of 0.45, contributing to its attractive valuation.
In the broader market context, Aarti Drugs has outperformed the Sensex over the past week and month, with returns of 3.13% and 7.07%, respectively, compared to the benchmark's 0.88% and 1.20%. Year-to-date, the stock has generated a return of 13.96%, significantly higher than the Sensex's 5.74%. While the stock has underperformed over the longer term, particularly in the 3-year and 5-year periods, its recent performance and strong fundamentals suggest a positive outlook, especially given the increase in profits by 20.4% over the past year, despite a modest overall return of 0.79%.